This page contains a Flash digital edition of a book.
PERU
tHE fREE tRADE AGREEMEnt WItH tHE Us
BRoUGHt IMPoRtAnt DYnAMIsM to tHE EConoMY
Data protection • Applicants may request a two-month extension of the original 12-month
• Law 1072 on pharmaceutical products and Law 1074 on agrochemicals,
term for fi ling a patent with a priority claim. For that purpose, the
which obligate health authorities, under certain conditions, not to disclose
applicant must fi le a sworn declaration explaining the reasons why the
confi dential product testing data submitted to them as part of mandatory
application could not be fi led within the 12-month original term and
product approval processes.
providing evidence to show that it was not possible despite the applicant’s
due diligence
Implementation of the free trade agreement with
• A provision has been approved allowing manufacturers of generic drugs
the Us
to use a patented ingredient in experiments and test marketing, as
required, for the sole purpose of obtaining approval by health authorities
• Law 29316, which amends, adds and regulates several provisions in order
and aimed at the commercialisation of the generic drug in the market
to implement the FTA with the United Sates.
aft er the expiration of the patent
Th e most important changes and developments brought by this legislation are: • Th e scope of non-patentable subject matter has been broadened to
biological materials which, in whole or in part, exist in nature. Earlier
Patents legislation was less precise, and it was understood that it referred only to
• Th e patent offi ce, at the request of an interested party, will adjust and
biological materials existing in nature as a whole
extend the term of the patent (except in the case of pharmaceutical • When a patented product or process has been developed from genetic
products and processes) when an unreasonable delay in the granting resources or traditional knowledge originated in the country, failure
process occurs. An unreasonable delay is one of more than fi ve years from by the patentee to have obtained the corresponding Access Contract
the fi ling date or more than three years from the applicant’s request for or License of Use, as required by Andean and local laws, will result in
patentability examination. Th e adjustment must be requested within 30 a number of possible sanctions. Th ese include a fi ne of up to 1,000 Tax
days of the grant Units (approximately $1.3 million), the payment of compensation or
www.worldipreview.com World Intellectual Property Review Digest 2009 123
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173
Produced with Yudu - www.yudu.com